ClinicalTrials.Veeva

Menu

Adaptations to Breast Cancer and Exercise (ABRACE)

J

João Henkin

Status

Enrolling

Conditions

Breast Cancer

Treatments

Other: Combined training
Other: Control group

Study type

Interventional

Funder types

Other

Identifiers

NCT03314168
72983017.3.0000.5347

Details and patient eligibility

About

This study aims to investigate the effects of different volumes of combined training on fatigue, neuromuscular variables, morphological, cardiorespiratory capacity, functionality, and quality of life, in breast cancer (BCa) women undergoing primary treatment. Two thirds will be the intervention group that will perform combined training, while the other third will be the control group that will have physiotherapy sessions.

Full description

Although chemotherapy and radiation are mainstream treatment modalities, patients will often experience treatment-related side effects such as impairments to the neuromuscular and cardiovascular systems and reduction in quality of life (QoL).To date, numerous positive effects on neuromuscular and aerobic parameters in response to resistance and aerobic training have been reported when both training modalities were simultaneously performed (i.e. combined training - COMB) in BCa patients. However, there is a lack of data regarding the prescription of this modality in BCa patients, as the necessary dose of resistance training for significant improve in fatigue, neuromuscular, and quality of life. In this sense, no previous studies investigate the effect of different volumes of resistance training in BCa patients, providing important informations about the prescription in this clinical population.

Enrollment

84 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Breast cancer diagnostic at I and II stages;
  • Adjuvant or neoadjuvant chemotherapy (≤50% of sessions completed);
  • More than 18 years.

Exclusion criteria

  • Current smoking
  • Diabetic neuropathy;
  • Hypertension uncontrolled;
  • Heart failure;
  • Clinical depression;
  • Skeletal muscle impairment which not allow physical exercise.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

84 participants in 3 patient groups

Control group
Active Comparator group
Description:
Patients who are randomized in control group will receive the usual care in their respective hospital.
Treatment:
Other: Control group
Single-set group
Experimental group
Description:
Patients who are randomized in Single-set (SS) group, will receive 12-week of combined training, twice a week, composed by 10 resistance exercises and 20-25 minutes aerobic exercise at 80-95% of the second ventilatory threshold heart rate in a cycle. One-single set will be performed per exercise at 60-80%1-RM, with 1-1,5min of rest between the exercises.
Treatment:
Other: Combined training
Multiple-sets group
Experimental group
Description:
Patients who are randomized in Multiples-set (MS) group, will receive 12-week of combined training, twice a week, composed by 10 resistance exercises and 20-25 minutes aerobic exercise at 80-95% of the second ventilatory threshold heart rate in a cycle. Regarding resistance exercises, three set will be performed per exercise at 60-80%1-RM, with 1-1,5min of rest between sets and the exercises.
Treatment:
Other: Combined training

Trial contacts and locations

2

Loading...

Central trial contact

Joao Henkin, BsC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems